5 Life Sciences IPOs in 2023—and the Future Forecast

Compared to recent years, 2023 has been a relative desert—or a winter—in terms of biotech IPO offerings. In 2022, for example, 47 IPOs raised a total of about $4 billion, while in 2021, 152 offerings brought more than $25 billion to the market, Reuters reported. So far this year, only 23 IPOs have been filed, according to DealForma, an online platform that tracks deals across the biopharma industry. The 12 that have since been completed have netted $1.6 billion, excluding the record-breaking $41 billion IPO filed by Johnson & Johnson’s Kenvue in May.